Camila Robles-Oteiza (IMAGE)
Caption
New research led by Camila Robles-Oteiza shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy.
Credit
Yale Cancer Center
Usage Restrictions
None
License
Licensed content